{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T07:08:36Z","timestamp":1792480116649,"version":"4.5.0"},"reference-count":57,"publisher":"Oxford University Press (OUP)","issue":"8","license":[{"start":{"date-parts":[[2025,8,21]],"date-time":"2025-08-21T00:00:00Z","timestamp":1755734400000},"content-version":"vor","delay-in-days":20,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,8,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Adverse drug reactions (ADRs) and adverse drug events (ADEs) are consistently reported to cause up to 30% of hospital admissions in older adults, resulting in significant morbidity, mortality and an added health economic burden.<\/jats:p>\n                    <jats:p>This systematic review aimed to establish the frequency of ADRs and ADEs as a cause of hospitalisation in older adults.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Standard databases and citations were searched from 2015 to 2025. Studies specifically assessing ADR and ADE prevalence and risk factors in older adults were included. The review was registered in PROSPERO (CRD42024613426) and quality was assessed using the Joanna Briggs Institute criteria with bias determined via ROBINS-E.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Nine studies underwent full evaluation. The reported prevalence of ADRs ranged from 3.3% to 23.1% and ADEs ranged from 11.75% to 18% as causes of hospitalisation. The median age of those included, in the respective studies, was between 77 and 86\u00a0years. Falls (19.4%\u201320.9%), delirium (7.3%\u201312.9%) and bleeding (8%\u201330.2%) were the most frequently encountered ADR\/ADEs causing hospitalisation. Anti-thrombotics (11.5%\u201330.2%) diuretics (14.7%\u201330.2%) and renin-angiotensin-aldosterone system (RAAS) inhibitors (7.5%\u20138.9%) accounted for the highest proportion of ADR\/ADE causative agents.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>This review has limitations stemming from the heterogeneity of the included studies and the exclusion of the grey literature. However, ADRs and ADEs remain a significant cause of hospital admissions in older patients. The possible preventability of these and their possible hospital admission avoidance highlights the critical need for further research into ADR\/ADE risk prediction methods in addition to co-morbidity and medication optimisation for older adults.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1093\/ageing\/afaf231","type":"journal-article","created":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T12:01:49Z","timestamp":1754049709000},"source":"Crossref","is-referenced-by-count":24,"title":["Hospital admissions due to adverse drug reactions and adverse drug events in older adults: a systematic review"],"prefix":"10.1093","volume":"54","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3801-7791","authenticated-orcid":false,"given":"Nicole","family":"Cosgrave","sequence":"first","affiliation":[{"name":"Royal College of Surgeons in Ireland\u2014Department of Medicine, Smurfit Building Beaumont Hospital Dublin 7 , Dublin ,","place":["Ireland"]},{"name":"Beaumont Hospital\u2014Department of Medicine, Hospital Road Beaumont Dublin 7 , Dublin ,","place":["Ireland"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juliane","family":"Frydenlund","sequence":"additional","affiliation":[{"name":"Royal College of Surgeons in Ireland\u2014Data Science Centre , Department of Population Health Sciences, Lower Mercer Street Dublin 2, Dublin ,","place":["Ireland"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francis","family":"Beirne","sequence":"additional","affiliation":[{"name":"Royal College of Surgeons in Ireland\u2014Department of Medicine , Dublin ,","place":["Ireland"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stuart","family":"Lee","sequence":"additional","affiliation":[{"name":"Beaumont Hospital\u2014Department of Medicine , Dublin ,","place":["Ireland"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Iman","family":"Faez","sequence":"additional","affiliation":[{"name":"Beaumont Hospital\u2014Department of Medicine , Dublin ,","place":["Ireland"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7137-5737","authenticated-orcid":false,"given":"Caitriona","family":"Cahir","sequence":"additional","affiliation":[{"name":"RCSI University of Medicine and Health Sciences\u2014Department of Population Health Sciences , Beaux Lane House Mercer Street, Dublin DO2 YN77 ,","place":["Ireland"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Williams","sequence":"additional","affiliation":[{"name":"RCSI\u2014Department of Medicine , Dublin, Leinster ,","place":["Ireland"]},{"name":"Beaumont Hospital\u2014Department of Geriatric and Stroke Medicine , Dublin, Leinster ,","place":["Ireland"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2025,8,21]]},"reference":[{"key":"2025092303112900400_ref1","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1016\/S0140-6736(00)02799-9","article-title":"Adverse drug reactions: definitions, diagnosis, and management","volume":"356","author":"Edwards","year":"2000","journal-title":"Lancet"},{"key":"2025092303112900400_ref2","volume-title":"Medication without Harm","author":"Challenge"},{"key":"2025092303112900400_ref3","doi-asserted-by":"crossref","first-page":"795","DOI":"10.7326\/0003-4819-140-10-200405180-00009","article-title":"Clarifying adverse drug events: a clinician's guide to terminology, documentation, and reporting","volume":"140","author":"Nebeker","year":"2004","journal-title":"Ann Intern Med"},{"key":"2025092303112900400_ref4","volume-title":"Definitions and Standards for Expe-Dited Reporting","author":"Committee"},{"key":"2025092303112900400_ref5","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1007\/BF03319101","article-title":"Adverse drug events as a cause of hospitalization in older adults","volume":"35","author":"Salvi","year":"2012","journal-title":"Drug Saf"},{"key":"2025092303112900400_ref6","doi-asserted-by":"crossref","first-page":"1029067","DOI":"10.3389\/fphar.2022.1029067","article-title":"Adverse drug reactions in an ageing PopulaTion (ADAPT) study: prevalence and risk factors associated with adverse drug reaction-related hospital admissions in older patients","volume":"13","author":"Cahir","year":"2023","journal-title":"Front Pharmacol"},{"key":"2025092303112900400_ref7","doi-asserted-by":"crossref","first-page":"e4439","DOI":"10.1371\/journal.pone.0004439","article-title":"Adverse drug reactions in hospital in-patients: a prospective analysis of 3695 patient-episodes","volume":"4","author":"Davies","year":"2009","journal-title":"PLoS One"},{"key":"2025092303112900400_ref8","doi-asserted-by":"crossref","first-page":"S73","DOI":"10.4103\/0976-500X.120957","article-title":"Clinical and economic burden of adverse drug reactions","volume":"4","author":"Sultana","year":"2013","journal-title":"J Pharmacol Pharmacother"},{"key":"2025092303112900400_ref9","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1136\/bmj.332.7550.1109","article-title":"Adverse drug reactions result in 250 000 UK admissions a year. BMJ","volume":"332","author":"Hitchen","year":"2006","journal-title":"Br Med J"},{"key":"2025092303112900400_ref10","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1016\/j.jval.2012.05.007","article-title":"Costs of adverse drug events in German hospitals\u2014a microcosting study","volume":"15","author":"Rottenkolber","year":"2012","journal-title":"Value Health"},{"key":"2025092303112900400_ref11","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1007\/s00228-023-03552-x","article-title":"Costs associated with adverse drug reactions in an older population admitted to hospital: a prospective cohort study","volume":"79","author":"Bennett","year":"2023","journal-title":"Eur J Clin Pharmacol"},{"key":"2025092303112900400_ref12","doi-asserted-by":"crossref","first-page":"1192","DOI":"10.1111\/imj.13961","article-title":"Hospitalisation and morbidity due to adverse drug reactions in elderly patients: a single-Centre study","volume":"48","author":"Ognibene","year":"2018","journal-title":"Intern Med J"},{"key":"2025092303112900400_ref13","doi-asserted-by":"crossref","first-page":"91","DOI":"10.4103\/0976-500X.110872","article-title":"Adverse drug reactions in the elderly","volume":"4","author":"Brahma","year":"2013","journal-title":"J Pharmacol Pharmacother"},{"key":"2025092303112900400_ref14","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1080\/17425255.2021.1839413","article-title":"Alterations in drug disposition in older adults: a focus on geriatric syndromes","volume":"17","author":"Maher","year":"2021","journal-title":"Expert Opin Drug Metab Toxicol"},{"key":"2025092303112900400_ref15","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1093\/ageing\/afv166","article-title":"Use of a frailty index to identify potentially inappropriate prescribing and adverse drug reaction risks in older patients","volume":"45","author":"","year":"2016","journal-title":"Age Ageing"},{"key":"2025092303112900400_ref16","article-title":"Adverse drug events and adverse drug reaction-related hospital admissions in older adults \u2013 a systematic review","author":"Cosgrave"},{"key":"2025092303112900400_ref17","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1007\/s12630-008-9007-4","article-title":"Posing the research question: not so simple","volume":"56","author":"Thabane","year":"2009","journal-title":"Can J Anesth\/J Can Anesth"},{"key":"2025092303112900400_ref18","doi-asserted-by":"crossref","first-page":"105906","DOI":"10.1016\/j.ijsu.2021.105906","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews","volume":"88","author":"Page","year":"2021","journal-title":"Int J Surg"},{"key":"2025092303112900400_ref19","author":"Institute, J.B","year":"2020","journal-title":"Checklist for analytical cross sectional studies"},{"key":"2025092303112900400_ref20","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1016\/S0140-6736(07)61602-X","article-title":"The strengthening the reporting of observational studies in epidemiology (STROBE) statement: guidelines for reporting observational studies","volume":"370","author":"Von Elm","year":"2007","journal-title":"Lancet"},{"key":"2025092303112900400_ref21","doi-asserted-by":"crossref","first-page":"108602","DOI":"10.1016\/j.envint.2024.108602","article-title":"A tool to assess risk of bias in non-randomized follow-up studies of exposure effects (ROBINS-E)","volume":"186","author":"Higgins","year":"2024","journal-title":"Environ Int"},{"key":"2025092303112900400_ref22","doi-asserted-by":"crossref","first-page":"105041","DOI":"10.1016\/j.jamda.2024.105041","volume":"25","author":"Ali","year":"2024","journal-title":"J Am Med Dir Assoc"},{"key":"2025092303112900400_ref23","doi-asserted-by":"crossref","first-page":"358","DOI":"10.3389\/fphar.2016.00358","article-title":"Hospitalizations due to adverse drug events in the elderly\u2014a retrospective register study","volume":"7","author":"Laatikainen","year":"2016","journal-title":"Front Pharmacol"},{"key":"2025092303112900400_ref24","doi-asserted-by":"crossref","first-page":"1218","DOI":"10.1007\/s11096-021-01237-y","article-title":"Hospital admissions to geriatric ward related to adverse drug events: a cross-sectional study from the Czech Republic","volume":"43","author":"Ma\u0159\u00edkov\u00e1","year":"2021","journal-title":"Int J Clin Pharm"},{"key":"2025092303112900400_ref25","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1007\/s40264-017-0528-z","article-title":"Adverse drug reaction-related hospitalizations in elderly Australians: a prospective cross-sectional study in two Tasmanian hospitals","volume":"40","author":"Parameswaran, Nair","year":"2017","journal-title":"Drug Saf"},{"key":"2025092303112900400_ref26","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1007\/s00228-015-1974-0","article-title":"Adverse drug reactions leading to urgent hospital admission in an elderly population: prevalence and main features","volume":"72","author":"Pedr\u00f3s","year":"2016","journal-title":"Eur J Clin Pharmacol"},{"key":"2025092303112900400_ref27","first-page":"07030","volume-title":"Fundamental & Clinical Pharmacology","author":"Bres","year":"2023"},{"key":"2025092303112900400_ref28","doi-asserted-by":"crossref","first-page":"afae276","DOI":"10.1093\/ageing\/afae276","article-title":"Use of a trigger tool to describe and screen drug-related hospital admissions in older adults: the TRIGGAge retrospective cohort study","volume":"54","author":"Dauny","year":"2025","journal-title":"Age Ageing"},{"key":"2025092303112900400_ref29","doi-asserted-by":"crossref","first-page":"1142","DOI":"10.1001\/archinternmed.2010.153","article-title":"Development and validation of a score to assess risk of adverse drug reactions among in-hospital patients 65 years or older: the GerontoNet ADR risk score","volume":"170","author":"Onder","year":"2010","journal-title":"Arch Intern Med"},{"key":"2025092303112900400_ref30","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1007\/s00228-017-2225-3","article-title":"Hospital admissions due to adverse drug reactions in the elderly. A meta-analysis","volume":"73","author":"Oscanoa","year":"2017","journal-title":"Eur J Clin Pharmacol"},{"key":"2025092303112900400_ref31","doi-asserted-by":"crossref","first-page":"e0161705","DOI":"10.1371\/journal.pone.0161705","article-title":"Who lives where and does it matter? Changes in the health profiles of older people living in long term care and the community over two decades in a high income country","volume":"11","author":"Matthews","year":"2016","journal-title":"PLoS One"},{"key":"2025092303112900400_ref32","doi-asserted-by":"crossref","DOI":"10.3399\/BJGPO.2021.0167","article-title":"Excessive polypharmacy and potentially inappropriate prescribing in 147 care homes: a cross-sectional study","volume":"5","author":"MacRae","year":"2021","journal-title":"BJGP open"},{"key":"2025092303112900400_ref33","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1080\/13814788.2017.1288211","article-title":"Prevalence of inappropriate medication use in residential long-term care facilities for the elderly: a systematic review","volume":"23","author":"Storms","year":"2017","journal-title":"Eur J Gen Pract"},{"key":"2025092303112900400_ref34","doi-asserted-by":"crossref","first-page":"44","DOI":"10.3928\/00989134-20140310-01","article-title":"Prevalence, views, and impact of advance directives among older adults","volume":"40","author":"Kossman","year":"2014","journal-title":"J Gerontol Nurs"},{"key":"2025092303112900400_ref35","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1007\/s41999-021-00481-9","article-title":"Adverse drug reactions in older adults: a narrative review of the literature","volume":"12","author":"Zazzara","year":"2021","journal-title":"European geriatric medicine"},{"key":"2025092303112900400_ref36","doi-asserted-by":"crossref","first-page":"83","DOI":"10.12788\/jhm.2685","article-title":"The association of geriatric syndromes with hospital outcomes","volume":"12","author":"Romero-Ortuno","year":"2017","journal-title":"J Hosp Med"},{"key":"2025092303112900400_ref37","first-page":"pe24","article-title":"From bedside to bench: research agenda for frailty. Science of aging knowledge","volume":"2005","author":"Fried","year":"2005","journal-title":"Environment"},{"key":"2025092303112900400_ref38","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1016\/S0140-6736(12)62167-9","article-title":"Frailty in elderly people","volume":"381","author":"Clegg","year":"2013","journal-title":"Lancet"},{"key":"2025092303112900400_ref39","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1503\/cmaj.050051","article-title":"A global clinical measure of fitness and frailty in elderly people","volume":"173","author":"Rockwood","year":"2005","journal-title":"CMAJ"},{"key":"2025092303112900400_ref40","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1001\/archinte.165.7.790","article-title":"Concealed renal insufficiency and adverse drug reactions in elderly hospitalized patients","volume":"165","author":"Corsonello","year":"2005","journal-title":"Arch Intern Med"},{"key":"2025092303112900400_ref41","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1111\/bcp.12596","article-title":"Adverse drug reactions in special populations\u2013the elderly","volume":"80","author":"Davies","year":"2015","journal-title":"Br J Clin Pharmacol"},{"key":"2025092303112900400_ref42","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1016\/S0735-6757(96)90147-3","article-title":"Drug-drug and drug-disease interactions in the ED: analysis of a high-risk population","volume":"14","author":"Goldberg","year":"1996","journal-title":"Am J Emerg Med"},{"key":"2025092303112900400_ref43","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1111\/jgs.15767","article-title":"American Geriatrics Society 2019 updated AGS beers criteria\u00ae for potentially inappropriate medication use in older adults","volume":"67","year":"2019","journal-title":"J Am Geriatr Soc"},{"key":"2025092303112900400_ref44","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1007\/s41999-023-00777-y","article-title":"STOPP\/START criteria for potentially inappropriate prescribing in older people: version 3","volume":"14","author":"O\u2019Mahony","year":"2023","journal-title":"European geriatric medicine"},{"key":"2025092303112900400_ref45","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1007\/s40266-022-00940-3","article-title":"Scoping review of studies evaluating frailty and its association with medication harm","volume":"39","author":"Lam","year":"2022","journal-title":"Drugs Aging"},{"key":"2025092303112900400_ref46","article-title":"Risk prediction models for adverse drug reactions and adverse drug events in older adults\u2014a systematic review and meta-analysis","volume":"81","author":"Cosgrave","journal-title":"Eur J Clin Pharmacol"},{"key":"2025092303112900400_ref47","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1111\/j.1365-2125.2007.03071.x","article-title":"Does pharmacist-led medication review help to reduce hospital admissions and deaths in older people? A systematic review and meta-analysis","volume":"65","author":"Holland","year":"2008","journal-title":"Br J Clin Pharmacol"},{"key":"2025092303112900400_ref48","article-title":"Medication review in hospitalised patients to reduce morbidity and mortality","volume":"20","author":"Christensen","journal-title":"Cochrane Database Syst Rev"},{"key":"2025092303112900400_ref49","article-title":"A comprehensive review on unveiling the journey of digoxin: past, present, and future perspectives","volume":"16","author":"Khandelwal","journal-title":"Cureus"},{"key":"2025092303112900400_ref50","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.thromres.2022.09.006","article-title":"A ten-year review of the impact of the transition from warfarin to direct oral anticoagulant\u2013has venous thromboembolism treatment become safer?","volume":"219","author":"Lui","year":"2022","journal-title":"Thromb Res"},{"key":"2025092303112900400_ref51","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1007\/s41999-022-00649-x","article-title":"Performance of a trigger tool for detecting adverse drug reactions in patients with polypharmacy acutely admitted to the geriatric ward","volume":"13","author":"Noorda","year":"2022","journal-title":"European Geriatric Medicine"},{"key":"2025092303112900400_ref52","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1111\/jocn.12714","article-title":"Patient-specific risk factors of adverse drug events in adult inpatients\u2013evidence detected using the Global Trigger Tool method","volume":"24","author":"H\u00e4rk\u00e4nen","year":"2015","journal-title":"J Clin Nurs"},{"key":"2025092303112900400_ref53","doi-asserted-by":"crossref","first-page":"afab196","DOI":"10.1093\/ageing\/afab196","article-title":"Performance of a trigger tool for detecting drug-related hospital admissions in older people: analysis from the OPERAM trial","volume":"51","author":"Zerah","year":"2022","journal-title":"Age Ageing"},{"key":"2025092303112900400_ref54","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1007\/s11096-018-0768-8","article-title":"Assessment tool for hospital admissions related to medications: development and validation in older patients","volume":"41","author":"Kempen","year":"2019","journal-title":"Int J Clin Pharm"},{"key":"2025092303112900400_ref55","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1002\/pds.3747","article-title":"Quick assessment of drug-related admissions over time (QUADRAT study)","volume":"24","author":"Warl\u00e9-van Herwaarden","year":"2015","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"2025092303112900400_ref56","article-title":"Adverse drug reactions and events in an ageing PopulaTion risk prediction (ADAPTiP) tool: the development and validation of a model for predicting adverse drug reactions and events in older patients","volume":"16","author":"Frydenlund","journal-title":"European Geriatric Medicine"},{"key":"2025092303112900400_ref57","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1111\/j.1447-0594.2006.00341.x","article-title":"Reviewing the definition of \u201celderly\u201d","volume":"6","author":"Orimo","year":"2006","journal-title":"Geriatr Gerontol Int"}],"container-title":["Age and Ageing"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/ageing\/article-pdf\/54\/8\/afaf231\/64100787\/afaf231.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ageing\/article-pdf\/54\/8\/afaf231\/64100787\/afaf231.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,23]],"date-time":"2025-09-23T07:11:42Z","timestamp":1758611502000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ageing\/article\/doi\/10.1093\/ageing\/afaf231\/8239079"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,1]]},"references-count":57,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2025,8,1]]}},"URL":"https:\/\/doi.org\/10.1093\/ageing\/afaf231","relation":{},"ISSN":["0002-0729","1468-2834"],"issn-type":[{"value":"0002-0729","type":"print"},{"value":"1468-2834","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2025,8]]},"published":{"date-parts":[[2025,8,1]]},"article-number":"afaf231"}}